Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Nervive, Inc.
company
About
Nervive, Inc., is a for-profit C-corp that is developing the VitalFlow, an emergency treatment for stroke and traumatic brain injury.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3.10M
- Industries
- Health Care,Medical,Wellness
- Founded date
- Dec 31, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Close
Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury.Founded in 2013, Nervive is headquartered in Akron, Ohio.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3.10M
Nervive, Inc. has raised a total of
$3.10M
in funding over 2 rounds. Their latest funding was raised on
Oct 6, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 6, 2017 | Grant | $3.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Nervive, Inc. is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
